Biomarkers for non-cancerous diseases
Biomarkers plan an important role in various neurological and cardiovascular diseases. The diseases which are incurable from ages are being offered a possible treatment and easy diagnosis with the help of advancements in biomarkers through different diagnostics and imaging technologies. Biomarkers are used in many other non-cancerous diseases.
Related Conference of Biomarkers for non-cancerous diseases
Biomarkers for non-cancerous diseases Conference Speakers
Recommended Sessions
- Biomarkers & Next-Generation Sequencing
- Biomarkers based on epidemiological investigations
- Biomarkers for Cancer Diagnosis
- Biomarkers in Drug discovery and development
- Biomarkers of Cardiovascular disorders
- Discovery of new biomarkers/validation/technologies
- Entrepreneur Investments Meet
- Imaging Technologies and Diagnostic tests of Biomarkers
- Biomarkers for Early Diagnosis and Prognosis
- Biomarkers for non-cancerous diseases
- Biomarkers in Diagnosis: Challenges and Approaches
- Biomarkers in Disease Treatment
- Biomarkers in Immune-Oncology
- Biomarkers of Disorders of the Nervous System
- Biomarkers: Validation & Verification
- Clinical and Biomedical Engineering
- Clinical Research & Biomarkers
- Genomic Biomarkers in Clinical Development
Related Journals
Are you interested in
- Advances in Separation Techniques - ANALYTICA ACTA 2024 (France)
- Analytical Chemistry and Methodology - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Clinical Chemistry - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Thermal analysis - ANALYTICA ACTA 2024 (France)
- Bioanalytical Methodology - ANALYTICA ACTA 2024 (France)
- Biochemistry - ANALYTICA ACTA 2024 (France)
- Biomarkers & Next-Generation Sequencing - Biomarkers 2024 (Italy)
- Biomarkers based on epidemiological investigations - Biomarkers 2024 (Italy)
- Biomarkers for Cancer Diagnosis - Biomarkers 2024 (Italy)
- Biomarkers for Early Diagnosis and Prognosis - Biomarkers 2024 (Italy)
- Biomarkers for non-cancerous diseases - Biomarkers 2024 (Italy)
- Biomarkers in Diagnosis: Challenges and Approaches - Biomarkers 2024 (Italy)
- Biomarkers in Disease Treatment - Biomarkers 2024 (Italy)
- Biomarkers in Drug discovery and development - Biomarkers 2024 (Italy)
- Biomarkers in Immune-Oncology - Biomarkers 2024 (Italy)
- Biomarkers of Cardiovascular disorders - Biomarkers 2024 (Italy)
- Biomarkers of Disorders of the Nervous System - Biomarkers 2024 (Italy)
- Biomarkers: Validation & Verification - Biomarkers 2024 (Italy)
- Biopolymers and Biomaterials - ANALYTICA ACTA 2024 (France)
- Chromatography - ANALYTICA ACTA 2024 (France)
- Clinical and Biomedical Engineering - Biomarkers 2024 (Italy)
- Clinical Diagnostics Equipment and Kits - ANALYTICA ACTA 2024 (France)
- Clinical Research & Biomarkers - Biomarkers 2024 (Italy)
- Discovery of new biomarkers/validation/technologies - Biomarkers 2024 (Italy)
- Electrophoresis - ANALYTICA ACTA 2024 (France)
- Entrepreneur Investments Meet - Biomarkers 2024 (Italy)
- Environmental Analytical Chemistry - ANALYTICA ACTA 2024 (France)
- Genomic Biomarkers in Clinical Development - Biomarkers 2024 (Italy)
- Hyphenated Techniques - ANALYTICA ACTA 2024 (France)
- Imaging Technologies and Diagnostic tests of Biomarkers - Biomarkers 2024 (Italy)
- Innovation in Food Analysis & Testing - ANALYTICA ACTA 2024 (France)
- Mass Spectrometry - ANALYTICA ACTA 2024 (France)
- Method development and validation - ANALYTICA ACTA 2024 (France)
- Microscopy - ANALYTICA ACTA 2024 (France)
- New Instrumentation and Equipment - ANALYTICA ACTA 2024 (France)
- Novel Optical Sensors and Biosensors - ANALYTICA ACTA 2024 (France)
- Pharmaceutical Analytics - ANALYTICA ACTA 2024 (France)
- Polymer Science and Material Science - ANALYTICA ACTA 2024 (France)
- Proteomics and its applications - ANALYTICA ACTA 2024 (France)
- Regulatory issues and Biosafety challenges in bioanalysis - ANALYTICA ACTA 2024 (France)
- Regulatory Issues and Biosafety Challenges in Bioanalysis - ANALYTICA ACTA 2024 (France)
- Spectroscopy - ANALYTICA ACTA 2024 (France)